NCT05016895View on ClinicalTrials.gov

REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire

NACompletedINTERVENTIONAL

Enrollment

767,535

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2024

Conditions

Child Mortality

Interventions

DRUG

Single-dose azithromycin

Bi-annual mass, community-based distribution of single-dose azithromycin to children ages 1 to 11 months.

Trial Locations (1)

Unknown

FHI 360, Abidjan

All Listed Sponsors

collaborator

Ministry of Health, Ivory Coast

UNKNOWN

lead

FHI 360

OTHER

NCT05016895 - REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire | Biotech Hunter | Biotech Hunter